Target (CBDY) Other Non-Current Liabilities (2019 - 2026)

Target (CBDY) reported Other Non-Current Liabilities of $10.4 million for Q1 2026, up 31612124.24% year-over-year from N/an in Q1 2025, and up 0.68% quarter-over-quarter from $10.4 million in Q4 2025.

Target (CBDY) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends

Target (CBDY) has 8 years of Other Non-Current Liabilities data on file, last reported at $10.4 million in Q1 2026.

  • Other Non-Current Liabilities for Q1 2026 came in at $10.4 million, up 31612124.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.4 million (up 31612124.24% YoY), and the FY2025 annual result was $10.4 million, up 24670319.05% from the prior year.
  • Other Non-Current Liabilities climbed to $10.4 million in Q1 2026 per CBDY's latest filing, from $10.4 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $10.4 million in Q1 2026 and troughed at $7.0 in Q2 2025.
  • A 5-year average of $1.8 million and a median of $647.0 in 2024 frame the typical range for Other Non-Current Liabilities.
  • The sharpest annual moves came in 2022 and 2026: Other Non-Current Liabilities sank 99.98% in 2022, then surged 31612124.24% in 2026.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $489.0 in 2022, then retreated by 27.4% to $355.0 in 2023, then plunged by 88.17% to $42.0 in 2024, then soared by 24670319.05% to $10.4 million in 2025, then rose by 0.68% to $10.4 million in 2026.
  • Business Quant data shows CBDY's Other Non-Current Liabilities at $10.4 million in Q1 2026, $10.4 million in Q4 2025, and $10.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Target - - 191,787.00

Historic Data

Download Data
DateValue
Mar 31, 2026 10.43 Mn
Dec 31, 2025 10.36 Mn
Sep 30, 2025 10.20 Mn
Jun 30, 2025 7.00
Mar 31, 2025 33.00
Dec 31, 2024 42.00
Sep 30, 2024 414.00
Jun 30, 2024 647.00
Mar 31, 2024 696.00
Dec 31, 2023 355.00
Sep 30, 2023 1,770.00
Jun 30, 2023 931.00
Mar 31, 2023 345.00
Dec 31, 2022 489.00
Sep 30, 2022 468.00
Jun 30, 2022 764.00
Mar 31, 2022 1,080.00
Dec 31, 2021 22,095.00
Sep 30, 2021 744,802.00
Jun 30, 2021 3.59 Mn